e-learning
resources
Stockholm 2007
Monday 17.09.2007
Interstitial lung disease: diagnostic and therapeutic novelties
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The proteomic analysis of BAL from patients with langerhans cell histiocytosis (LCH)
E. Bargagli, R. Cianti, N. Nikiforakis, B. Magi, M. G. Perari, L. Bini, P. Rottoli (Siena, Italy)
Source:
Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties
Session:
Interstitial lung disease: diagnostic and therapeutic novelties
Session type:
Oral Presentation
Number:
1572
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Bargagli, R. Cianti, N. Nikiforakis, B. Magi, M. G. Perari, L. Bini, P. Rottoli (Siena, Italy). The proteomic analysis of BAL from patients with langerhans cell histiocytosis (LCH). Eur Respir J 2007; 30: Suppl. 51, 1572
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The anlysis of trace elements in BAL of patients with diffuse lung diseases and Langherans cell histiocytosis
Source: Eur Respir J 2007; 30: Suppl. 51, 587s
Year: 2007
Langerhans cell histiocytosis: is it an ILD?
Source: Virtual Congress 2021 – Interstitial lung diseases
Year: 2021
Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH)
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Pneumothorax in patients with Langerhans cell histiocytosis
Source: International Congress 2017 – The acute patient: the clinical point-of-view
Year: 2017
Adult pulmonary Langerhans' cell histiocytosis
Source: Eur Respir J 2006; 27: 1272-1285
Year: 2006
Genetic landscape of adult Langerhans cell histiocytosis with lung involvement
Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019
Year: 2020
Pulmonary Langerhans' cell histiocytosis
Source: Respipedia Article
Year: 2016
Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Chemotherapy in patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018
Protein analysis of bronchoalveolar lavage in pulmonary Langerhans-cell histiocytosis by a proteomic approach
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Genetic landscape of pulmonary langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018
How I manage pulmonary Langerhans cell histiocytosis
Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017
Year: 2017
Pulmonary langerhans¢ cell histiocytosis (LCH) - a retrospective review of 17 patients
Source: Eur Respir J 2003; 22: Suppl. 45, 43s
Year: 2003
Proteomic analysis of antioxidant proteins in bronchoalveolar lavage of patients with pulmonary Langerhans-cell histiocytosis
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011
Paediatric pulmonary Langerhans cell histiocytosis
Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020
Year: 2020
Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Pulmonary Langerhans‘ cell histiocytosis
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006
Pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008
Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept